Haymarket MediaFoundationOne CDx Approved as Companion Diagnostic for Capmatinib for METex14 NSCLC
The approval of capmatinib and its companion diagnostic is the first of its kind for this specific diagnosis, using next-generation sequencing to perform comprehensive genomic profiling of solid tumors. It now has FDA approval for 21 different agents.